On the occasion of the 70th anniversary of the founding of New China, YEEDOZENCOM moved to a new location - 9th Floor, Building 5, SDIC Fortune Plaza, No. 9 Guang'an Road, Fengtai District, Beijing.

It was an invigorating autumn climate on Sep. 1, 2019, on which date all students returned to school after vacation. The fresh force of Yeedozencom already trained on the knowledge and practice of clinical trials for 2 months finally embraced the special graduation ceremony on the very same day, which was the farewell to the past and the origin of their life in YeeDo ZonCom.

On Aug. 16, the National Medical Products Administration issued Xinhua Pharmaceutical (Gaomi) Co., Ltd., a wholly-owned subsidiary of Xinhua Pharmaceutical with the Approval Letter of Supplementary Application (Approval No.: 2019B03488) for the Cetirizine Hydrochloride Tablets (Trade Name: Minda; Specification: 10mg), which has passed the quality and efficacy consistency evaluation for generic drugs. As the partner of Xinhua Pharmaceutical, Yeedozencom has contributed to the success of such product in the consistency evaluation by overall conducting the organization, implementation and quality assurance of the clinical studies on such product.

The 9th Nanjing International DMPK Symposium was held in Nanjing on Jun. 28. This annual event was undertaken by Jiangsu Value – a platform engaged in the radiopharmaceutical pharmacokinetics and biospecimen analysis under the control of YeeDo ZenCom. The Nanjing International DMPK Symposium has been committed to promoting the development of pharmacokinetics in China, introducing the up-to-date overseas technologies for pharmacokinetics research, assisting the domestic pharmaceutical companies in reaching the international standards for IND DMPK studies, and establishing the effective platform for the direct exchange with the leading pharmacokinetics experts.

Henan Zhenshi Biotechnology Co., Ltd. (hereinafter referred to as “Zhenshi Biotechnology”) and Beijing Yeedozencom Health Technology Co., Ltd. (hereinafter referred to as “Yeedozencom”) entered into a strategic cooperation agreement on Jul. 4, 2019 to establish the all-round partnership in terms of the research and development of innovative drugs and generic drugs.

Blue sky, white clouds, high mountains, temples, incense burners, bronze bells, Buddha